Sumitomo Dainippon | 4506 - Cost Of Sales


Sumitomo Dainippon reported JPY51.26B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Astellas Pharma JPY 129.43B 19.7B Mar/2026
Chugai Pharma JPY 92.79B 5.23B Mar/2026
Daiichi Sankyo JPY 118.28B 37.7B Dec/2025
Eisai JPY 52.02B 931M Mar/2026
Kyowa Hakko Kirin JPY 33B 4.87B Mar/2026
M3 JPY 45.08B 461M Mar/2026
Otsuka Holdings JPY 174.09B 18.65B Mar/2026
Shionogi JPY 32.67B 7.02B Mar/2026
Sumitomo JPY 1.47T 64.45B Dec/2025
Sumitomo Dainippon JPY 51.26B 5.67B Mar/2026
Takeda JPY 560.54B 159.39B Mar/2026
Terumo JPY 151.3B 7.86B Mar/2026